Global Observatory on Donation and Transplantation (GODT): Organ donation and transplantation activities 2021 report. Available at https://www.transplant-observatory.org/2021-global-report-5/. Accessed November 11, 2024)| false
LentineKL, LamNN, SegevDL: Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol14: 597–608, 2019PubMed
LentineKL, LamNN, SegevDL: Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol 14: 597–608, 2019PubMed)| false
LamNN, LloydA, LentineKL, QuinnRR, RavaniP, HemmelgarnBR, et al.: Changes in kidney function follow living donor nephrectomy. Kidney Int98: 176–186, 2020PubMed
GargAX, ArnoldJB, CuerdenMS, DipchandC, FeldmanLS, GillJS, et al.: Hypertension and kidney function after living kidney donation. JAMA332: 287–299, 2024PubMed
GargAX, ArnoldJB, CuerdenMS, DipchandC, FeldmanLS, GillJS, : Hypertension and kidney function after living kidney donation. JAMA 332: 287–299, 2024PubMed)| false
KasiskeBL, Anderson-HaagTL, DuprezDA, KalilRS, KimmelPL, PesaventoTE, et al.: A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years. Kidney Int98: 168–175, 2020PubMed
KasiskeBL, Anderson-HaagTL, DuprezDA, KalilRS, KimmelPL, PesaventoTE, : A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years. Kidney Int 98: 168–175, 2020PubMed)| false
MuzaaleAD, MassieAB, WangM-C, MontgomeryRA, McBrideMA, WainrightJL, et al.: Risk of end-stage renal disease following live kidney donation. JAMA311: 579–586, 2014PubMed
GargAX, NevisIF, McArthurE, SontropJM, KovalJD, LamNN, DONOR Network, et al.: Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med372: 124–133, 2015PubMed
GargAX, NevisIF, McArthurE, SontropJM, KovalJD, LamNN, DONOR Network, : Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 372: 124–133, 2015PubMed)| false
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, et al.: Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant20: 3390–3400, 2020PubMed
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, : Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant 20: 3390–3400, 2020PubMed)| false
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, et al.: The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant20: 3379–3389, 2020PubMed
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, : The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant 20: 3379–3389, 2020PubMed)| false
RichardsonR, ConnellyM, DipchandC, GargAX, GhanekarA, HoudeI, Protocols Working Group of the Canadian Blood Services’ Living Donation Advisory Committee, et al.: Kidney paired donation protocol for participating donors 2014. Transplantation99: S1–S88, 2015PubMed
RichardsonR, ConnellyM, DipchandC, GargAX, GhanekarA, HoudeI, Protocols Working Group of the Canadian Blood Services’ Living Donation Advisory Committee, : Kidney paired donation protocol for participating donors 2014. Transplantation 99: S1–S88, 2015PubMed)| false
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, et al.: KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation101: S1–S109, 2017PubMed
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, : KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 101: S1–S109, 2017PubMed)| false
GargAX, LeveyAS, KasiskeBL, CheungM, LentineKL, KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team: Application of the 2017 KDIGO guideline for the evaluation and care of living kidney donors to clinical practice. Clin J Am Soc Nephrol15: 896–905, 2020PubMed
GargAX, LeveyAS, KasiskeBL, CheungM, LentineKL, KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team: Application of the 2017 KDIGO guideline for the evaluation and care of living kidney donors to clinical practice. Clin J Am Soc Nephrol 15: 896–905, 2020PubMed)| false
Organ Procurement and Transplantation: OPTN policies. 2024. Available at https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf. Accessed August 30, 2024)| false
GaillardF, CourbebaisseM, KamarN, RostaingL, JacquemontL, HourmantM, et al.: Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. Kidney Int95: 896–904, 2019PubMed
GaillardF, CourbebaisseM, KamarN, RostaingL, JacquemontL, HourmantM, : Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. Kidney Int 95: 896–904, 2019PubMed)| false
InkerLA, EneanyaND, CoreshJ, TighiouartH, WangD, SangY, Chronic Kidney Disease Epidemiology Collaboration, et al.: New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med385: 1737–1749, 2021PubMed
InkerLA, EneanyaND, CoreshJ, TighiouartH, WangD, SangY, Chronic Kidney Disease Epidemiology Collaboration, : New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385: 1737–1749, 2021PubMed)| false
DelgadoC, BawejaM, CrewsDC, EneanyaND, GadegbekuCA, InkerLA, et al.: A unifying approach for GFR estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. J Am Soc Nephrol32: 2994–3015, 2021PubMed
DelgadoC, BawejaM, CrewsDC, EneanyaND, GadegbekuCA, InkerLA, : A unifying approach for GFR estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. J Am Soc Nephrol 32: 2994–3015, 2021PubMed)| false
Al JurdiA, SafaK: Impact of the new glomerular filtration rate formulas on kidney function assessment in living kidney donors and candidates. Transplant Direct9: e1460, 2023PubMed
Al JurdiA, SafaK: Impact of the new glomerular filtration rate formulas on kidney function assessment in living kidney donors and candidates. Transplant Direct 9: e1460, 2023PubMed)| false
GoodsonDA, ChalupskyMR, WiegleyN, HuangY, ChiuM, BangH, et al.: GFR estimation in potential living kidney donors: Race- and nonrace-based equations and measured GFR. Kidney Med4: 100558, 2022PubMed
GoodsonDA, ChalupskyMR, WiegleyN, HuangY, ChiuM, BangH, : GFR estimation in potential living kidney donors: Race- and nonrace-based equations and measured GFR. Kidney Med 4: 100558, 2022PubMed)| false
LamNN, LentineKL, GargAX: End-stage renal disease risk in live kidney donors: What have we learned from two recent studies?Curr Opin Nephrol Hypertens23: 592–596, 2014PubMed
LamNN, LentineKL, GargAX: End-stage renal disease risk in live kidney donors: What have we learned from two recent studies?Curr Opin Nephrol Hypertens 23: 592–596, 2014PubMed)| false
O’KeeffeLM, RamondA, Oliver-WilliamsC, WilleitP, PaigeE, TrotterP, et al.: Mid- and long-term health risks in living kidney donors. Ann Intern Med168: 276–284, 2018PubMed
O’KeeffeLM, RamondA, Oliver-WilliamsC, WilleitP, PaigeE, TrotterP, : Mid- and long-term health risks in living kidney donors. Ann Intern Med 168: 276–284, 2018PubMed)| false
IbrahimHN, FoleyRN, ReuleSA, SpongR, KuklaA, IssaN, et al.: Renal function profile in White kidney donors: The first 4 decades. J Am Soc Nephrol27: 2885–2893, 2016PubMed
IbrahimHN, FoleyRN, ReuleSA, SpongR, KuklaA, IssaN, : Renal function profile in White kidney donors: The first 4 decades. J Am Soc Nephrol 27: 2885–2893, 2016PubMed)| false
MassieAB, MuzaaleAD, LuoX, ChowEKH, LockeJE, NguyenAQ, et al.: Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol28: 2749–2755, 2017PubMed
ThomasCP, DaloulR, LentineKL, GohhR, AnandPM, RasoulyHM, et al.: Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices. Am J Transplant23: 597–607, 2023PubMed
ThomasCP, DaloulR, LentineKL, GohhR, AnandPM, RasoulyHM, : Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices. Am J Transplant 23: 597–607, 2023PubMed)| false
CaliskanY, LeeB, WhelanA, AbualrubF, LentineKL, JittiratA: Evaluation of genetic kidney diseases in living donor kidney transplantation: Towards precision genomic medicine in donor risk assessment. Curr Transplant Rep9: 127–142, 2022PubMed
FosterMC, CoreshJ, FornageM, AstorBC, GramsM, FranceschiniN, et al.: APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol24: 1484–1491, 2013PubMed
DoshiMD, LiL, NaikAS, ThomasCP: APOL1 kidney risk variants and long-term kidney function in healthy middle-aged Black individuals: The Atherosclerosis Risk in Communities (ARIC) study. Kidney Med6: 100828, 2024PubMed
DoshiMD, LiL, NaikAS, ThomasCP: APOL1 kidney risk variants and long-term kidney function in healthy middle-aged Black individuals: The Atherosclerosis Risk in Communities (ARIC) study. Kidney Med 6: 100828, 2024PubMed)| false
LentineKL, MannonRB: Apolipoprotein L1: Role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens 29: 645–655, 2020PubMed)| false
DoshiMD, Ortigosa-GogginsM, GargAX, LiL, PoggioED, WinklerCA, et al.: APOL1 genotype and renal function of Black living donors. J Am Soc Nephrol29: 1309–1316, 2018PubMed
DoshiMD, Ortigosa-GogginsM, GargAX, LiL, PoggioED, WinklerCA, : APOL1 genotype and renal function of Black living donors. J Am Soc Nephrol 29: 1309–1316, 2018PubMed)| false
MerzkaniMA, MullanA, DenicA, D’CostaM, IversonR, KremersW, et al.: Renal function outcomes and kidney biopsy features of living kidney donors with hypertension. Clin Transplant35: e14293, 2021PubMed
MerzkaniMA, MullanA, DenicA, D’CostaM, IversonR, KremersW, : Renal function outcomes and kidney biopsy features of living kidney donors with hypertension. Clin Transplant 35: e14293, 2021PubMed)| false
HelgesonES, VempatiS, PalzerEF, MjoenG, HaugenAJ, MatasAJ: Development and validation of a hypertension risk calculator for living kidney donors. Transplantation107: 1373–1379, 2023PubMed
HelgesonES, VempatiS, PalzerEF, MjoenG, HaugenAJ, MatasAJ: Development and validation of a hypertension risk calculator for living kidney donors. Transplantation 107: 1373–1379, 2023PubMed)| false
Al AmmaryF, LuoX, MuzaaleAD, MassieAB, CrewsDC, WaldramMM, et al.: Risk of ESKD in older live kidney donors with hypertension. Clin J Am Soc Nephrol14: 1048–1055, 2019PubMed
Al AmmaryF, LuoX, MuzaaleAD, MassieAB, CrewsDC, WaldramMM, : Risk of ESKD in older live kidney donors with hypertension. Clin J Am Soc Nephrol 14: 1048–1055, 2019PubMed)| false
NaikAS, CibrikDM, SakhujaA, SamaniegoM, LuY, ShahinianV, et al.: Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors. Am J Transplant18: 642–649, 2018PubMed
NaikAS, CibrikDM, SakhujaA, SamaniegoM, LuY, ShahinianV, : Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors. Am J Transplant 18: 642–649, 2018PubMed)| false
BielopolskiD, YeminiR, GravetzA, YoskovitchO, KeidarA, CarmeliI, et al.: Bariatric surgery in severely obese kidney donors before kidney transplantation: A retrospective study. Transplantation107: 2018–2027, 2023PubMed
LockeJE, ReedRD, MassieA, MacLennanPA, SawinskiD, KumarV, et al.: Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int91: 699–703, 2017PubMed
LockeJE, ReedRD, MassieA, MacLennanPA, SawinskiD, KumarV, : Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int 91: 699–703, 2017PubMed)| false
LockeJE, ReedRD, MassieAB, MacLennanPA, SawinskiD, KumarV, et al.: Obesity and long-term mortality risk among living kidney donors. Surgery166: 205–208, 2019PubMed
ReedRD, McLeodMC, MacLennanPA, KumarV, PittmanSE, MaynorAG, et al.: Change in body mass index and attributable risk of new-onset hypertension among obese living kidney donors. Ann Surg278: e115–e122, 2023PubMed
ReedRD, McLeodMC, MacLennanPA, KumarV, PittmanSE, MaynorAG, : Change in body mass index and attributable risk of new-onset hypertension among obese living kidney donors. Ann Surg 278: e115–e122, 2023PubMed)| false
KillianAC, ReedRD, McLeodMC, MacLennanPA, KumarV, PittmanSE, et al.: Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study. PLoS One17: e0276882, 2022PubMed
KillianAC, ReedRD, McLeodMC, MacLennanPA, KumarV, PittmanSE, : Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study. PLoS One 17: e0276882, 2022PubMed)| false
AubertO, YooD, ZielinskiD, CozziE, CardilloM, DürrM, et al.: COVID-19 pandemic and worldwide organ transplantation: A population-based study. Lancet Public Health6: e709–e719, 2021PubMed
AubertO, YooD, ZielinskiD, CozziE, CardilloM, DürrM, : COVID-19 pandemic and worldwide organ transplantation: A population-based study. Lancet Public Health 6: e709–e719, 2021PubMed)| false
SalvalaggioPR, FerreiraGF, CaliskanY, VestLS, SchnitzlerMA, de Sandes-FreitasTV, et al.: An international survey on living kidney donation and transplant practices during the COVID-19 pandemic. Transpl Infect Dis23: e13526, 2021PubMed
SalvalaggioPR, FerreiraGF, CaliskanY, VestLS, SchnitzlerMA, de Sandes-FreitasTV, : An international survey on living kidney donation and transplant practices during the COVID-19 pandemic. Transpl Infect Dis 23: e13526, 2021PubMed)| false
Al AmmaryF, MotterJD, SungHC, LentineKL, SharfuddinA, KumarV, et al.: Telemedicine services for living kidney donation: A US survey of multidisciplinary providers. Am J Transplant22: 2041–2051, 2022PubMed
Al AmmaryF, MotterJD, SungHC, LentineKL, SharfuddinA, KumarV, : Telemedicine services for living kidney donation: A US survey of multidisciplinary providers. Am J Transplant 22: 2041–2051, 2022PubMed)| false
KuteV, Shankar RayD, DalalS, Hegde US, GodaraS, PathakV, et al.: A multicenter cohort study from India of ABO-incompatible kidney transplantation in post–COVIC-19 patients. Transplant Proc54: 2652–2657, 2022PubMed
KuteV, Shankar RayD, DalalS, Hegde US, GodaraS, PathakV, : A multicenter cohort study from India of ABO-incompatible kidney transplantation in post–COVIC-19 patients. Transplant Proc 54: 2652–2657, 2022PubMed)| false
LamNN, LentineKL, HemmelgarnB, KlarenbachS, QuinnRR, LloydA, et al.: Follow-up care of living kidney donors in Alberta, Canada. Can J Kidney Health Dis5: 2054358118789366, 2018PubMed
LamNN, LentineKL, HemmelgarnB, KlarenbachS, QuinnRR, LloydA, : Follow-up care of living kidney donors in Alberta, Canada. Can J Kidney Health Dis 5: 2054358118789366, 2018PubMed)| false
HendersonML, ThomasAG, ShafferA, MassieAB, LuoX, HolscherCM, et al.: The national landscape of living kidney donor follow-up in the United States. Am J Transplant17: 3131–3140, 2017PubMed
HendersonML, ThomasAG, ShafferA, MassieAB, LuoX, HolscherCM, : The national landscape of living kidney donor follow-up in the United States. Am J Transplant 17: 3131–3140, 2017PubMed)| false
LamNN, MuiruAN, TietjenA, HaysRE, XiaoH, GargAX, et al.: Associations of lack of insurance and other sociodemographic traits with follow-up after living kidney donation. Am J Kidney Dis80: 683–685, 2022PubMed
LamNN, MuiruAN, TietjenA, HaysRE, XiaoH, GargAX, : Associations of lack of insurance and other sociodemographic traits with follow-up after living kidney donation. Am J Kidney Dis 80: 683–685, 2022PubMed)| false
DhallaA, LloydA, LentineKL, GargAX, QuinnRR, RavaniP, et al.: Long-term outcomes for living kidney donors with early guideline-concordant follow-up care: A retrospective cohort study. Can J Kidney Health Dis10: 20543581231158067–9, 2023PubMed
DhallaA, LloydA, LentineKL, GargAX, QuinnRR, RavaniP, : Long-term outcomes for living kidney donors with early guideline-concordant follow-up care: A retrospective cohort study. Can J Kidney Health Dis 10: 20543581231158067–9, 2023PubMed)| false
LentineKL, DewMA, XiaoH, WisniewskiA, LevanML, Al AmmaryF, et al.: Factors enabling transplant program participation in the Scientific Registry of Transplant Recipients (SRTR) Living Donor Collective: A national survey. Clin Transplant37: e14908, 2023PubMed
LentineKL, DewMA, XiaoH, WisniewskiA, LevanML, Al AmmaryF, : Factors enabling transplant program participation in the Scientific Registry of Transplant Recipients (SRTR) Living Donor Collective: A national survey. Clin Transplant 37: e14908, 2023PubMed)| false
LentineKL, WatermanAD, CooperM, NagralS, GardinerD, SpiroM, Donation Workgroup Collaborators, et al.: Expanding opportunities for living donation: Recommendations from the 2023 Santander Summit to ensure donor protections, informed decision making, and equitable access [published online ahead of print Oct 22, 2024]. Transplantation doi:10.1097/TP.0000000000005124PubMed